FAST NEWS: Fosun Pharma hits pause button on share buyback program
The Latest: Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (2196.HK; 600196.SH) announced Monday it hasn't yet implemented a share buyback since announcing a plan on March 27 to buy back its A shares…
FAST NEWS: Junshi Biosciences announces A-Share buyback
The latest: Drug developer Shanghai Junshi Biosciences Co. Ltd. (1877.HK; 688180.SH) said on Sunday its board has approved a plan to buy back some of its A-shares for up to 58 yuan per…
FAST NEWS: CanSino Spends $21 Million on Share Buyback
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) said Friday it bought back about 670,000 of its Shanghai-listed A-shares for 147 million yuan ($20.8 million) as of Nov. 30, accounting for…
FAST NEWS: WuXi Biologics Announces $300 Million Share Buyback
The latest: Contract drugs services provider WuXi Biologics (Cayman) Inc. (2269.HK) announced on Monday its board of directors has approved a plan to buy back up to $300 million of the…
RELATED ARTICLES
-
Debt pressures cast cloud over Fosun Pharma results
2196.HK 600196.SHG -
Fosun International on cusp of new ‘asset-light’ era with latest sale
0656.HK
-
Fosun Tourism at crossroads as parent shops its two major assets
1992.HK 0656.HK
-
Fosun Tourism embarks on new journey with departure of big-name director
1992.HK
-
Fosun Tourism’s post-Covid holiday fizzles
1992.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
